Hypertrophic cardiomyopathy with longevity to 90 years or older

American Journal of Cardiology

Volumn 109, Issue 9, 2012, Pages 1341-1347

  Maron, Barry J ^a   Casey, Susan A ^a   Haas, Tammy S ^a   Kitner, Carrie L ^a   Garberich, Ross F ^a   Lesser, John R ^a  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC PATIENT; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; DATA BASE; DEMOGRAPHY; DISEASE MARKER; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART MURMUR; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LONGEVITY; MALE; MASS SCREENING; ONSET AGE; POPULATION; PREVALENCE; PRIORITY JOURNAL; REASSURANCE; STROKE; SUDDEN DEATH; SURVIVAL;

AGE FACTORS; AGE OF ONSET; AGED; AGED, 80 AND OVER; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MINNESOTA; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 84859792883     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.12.027     Document Type: Article

References (21)

1. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH III, Spirito P, Ten Cate FJ, Wigle ED; American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Committee to Develop an Expert Consensus Document on Hypertrophic Cardiomyopathy. J Am Coll Cardiol 2003;42:1687-1713. (Pubitemid 37383745)
2. Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, Mahon NG, McKenna WJ. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 2000;36:2212-2218.
3. Elliott PM, Gimeno B Jr, Mahon NG, Poloniecki JD, McKenna WJ. Relation between severity of left ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet 2001;357:420-424. (Pubitemid 32156140)
4. Maron BJ. Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Circulation 2010;121:445-456.
5. Lewis JF, Maron BJ. Elderly patients with hypertrophic cardiomyopathy: a subset with distinctive left ventricular morphology and progressive clinical course late in life. J Am Coll Cardiol 1989;13:36-45. (Pubitemid 19028674)
6. Dimitrow PP, Czarnecka D, Kawecka-Jaczca K, Dubiel JS. The influence of age on gender-specific differences in the left ventricular cavity size and contractility in patients with hypertrophic cardiomyopathy. Int J Cardiol 2003;88:11-16. (Pubitemid 36351403)
7. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy predicts the risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000;342:1778-1785. (Pubitemid 30390237)
8. Therneau TM, Grambsch PM. Modeling Survival Data. New York, New York: Springer, 2000.
9. Therneau TM, Offord J. Expected Survival Based on Hazard Rates (Update) 1999 (Mayo Clinic Biostatistics Technical Report 63). Rochester, Minnesota: Mayo Clinic, 1999.
10. Arias E, Curtin LR, Wei R, Anderson RN. U.S. decennial life tables for 1999-2001, United States life tables. Natl Vital Stat Rep 2008;57:1-36.
11. Klues HG, Roberts WC, Maron BJ. Morphologic determinants of echocardiographic patterns of mitral valve systolic anterior motion in obstructive hypertrophic cardiomyopathy. Circulation 1993;87:1570-1579. (Pubitemid 23133102)
12. Bos JM, Maron BJ, Ackerman MJ, Haas TS, Sorajja P, Nishimura RA, Gersh BJ, Ommen SR. Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy. Am J Cardiol 2010;106:1481-1486.
13. Spirito P, Autore C, Rapezzi C, Bernabò P, Badagliacca R, Maron MS, Bongioanni S, Coccolo F, Estes NA, Barillà CS, Biagini E, Quarta G, Conte MR, Bruzzi P, Maron BJ. Syncope and risk of sudden death in hypertrophic cardiomyopathy. Circulation 2009;119:1703-1710.
14. Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, Epstein AE, Almquist AK, Daubert JP, Lawrenz T, Boriani G, Estes NA III, Favale S, Piccininno M, Winters SL, Santini M, Betocchi S, Arribas F, Sherrid MV, Buja G, Semsarian C, Bruzzi P. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 2007;298:405-412. (Pubitemid 47124061)
15. Teare D. Asymmetrical hypertrophy of the heart in young adults. Br Heart J 1958;20:1-8.
16. Lewis JF, Maron BJ. Clinical and morphologic expression of hypertrophic cardiomyopathy in patients > 65 years of age. Am J Cardiol 1994;73:1105-1111.
17. Olivotto I, Maron MS, Adabag AS, Casey SA, Vargiu D, Link MS, Udelson JE, Cecchi F, Maron BJ. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. J Am Coll Cardiol 2005;46:480-487. (Pubitemid 41040290)
18. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, Cecchi F, Maron BJ. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 2003;348:295-303. (Pubitemid 36119984)
19. Seward JB, Casaclang-Verzosa G. Infiltrative cardiovascular diseases; cardiomyopathies that look alike. J Am Coll Cardiol 2010;55:1769-1779.
20. Ho C. Genetics and clinical destiny: improving care in hypertrophic cardiomyopathy. Circulation 2010;122:2430-2440.
21. Landstrom AP, Ackerman MJ. Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy. Circulation 2010;122:2441-2449.